TTM
$3.71B
YoY change
-18.5%
5Y CAGR
-1.9%
Peak year (2024)
$4.85B
Cumulative EBITDA
$108.79B
EBITDA history chart for Colgate-Palmolive (CL) from 1985 to 2025
Latest: $3.96B
EBITDA growth chart for Colgate-Palmolive (CL) from 1985 to 2025
Latest: -18.5%
EBITDA history table for Colgate-Palmolive (CL) from 1985 to 2025
| 2025 | $3.96B | -18.5% | −$897.00M | ||
| 2024 | $4.85B | +14.3% | +$607.00M | ||
| 2023 | $4.25B | +25.9% | +$874.00M | ||
| 2022 | $3.37B | -10.3% | −$388.00M | ||
| 2021 | $3.76B | -13.5% | −$586.00M | ||
| 2020 | $4.35B | +8.3% | +$334.00M | ||
| 2019 | $4.01B | -3.7% | −$156.00M | ||
| 2018 | $4.17B | +1.3% | +$53.00M | ||
| 2017 | $4.12B | -5.0% | −$215.00M | ||
| 2016 | $4.33B | +29.4% | +$985.00M | ||
| 2015 | $3.35B | -18.5% | −$760.00M | ||
| 2014 | $4.11B | -0.4% | −$15.00M | ||
| 2013 | $4.12B | -5.9% | −$259.00M | ||
| 2012 | $4.38B | +2.6% | +$111.00M | ||
| 2011 | $4.27B | +10.3% | +$397.00M | ||
| 2010 | $3.87B | -2.7% | −$106.00M | ||
| 2009 | $3.98B | +15.0% | +$518.40M | ||
| 2008 | $3.46B | +12.9% | +$394.50M | ||
| 2007 | $3.06B | +19.9% | +$509.50M | ||
| 2006 | $2.55B | -2.0% | −$51.50M | ||
| 2005 | $2.61B | +4.2% | +$104.30M | ||
| 2004 | $2.50B | +1.3% | +$33.20M | ||
| 2003 | $2.47B | +6.9% | +$159.00M | ||
| 2002 | $2.31B | +6.4% | +$138.60M | ||
| 2001 | $2.17B | +4.5% | +$92.70M | ||
| 2000 | $2.08B | +5.0% | +$98.30M | ||
| 1999 | $1.98B | +9.1% | +$165.50M | ||
| 1998 | $1.81B | +8.1% | +$136.40M | ||
| 1997 | $1.68B | +7.4% | +$116.00M | ||
| 1996 | $1.56B | +9.6% | +$136.30M | ||
| 1995 | $1.43B | +11.0% | +$141.30M | ||
| 1994 | $1.28B | +10.4% | +$120.60M | ||
| 1993 | $1.16B | +17.4% | +$172.80M | ||
| 1992 | $991.10M | +131.7% | +$563.30M | ||
| 1991 | $427.80M | -37.2% | −$253.10M | ||
| 1990 | $680.90M | +27.9% | +$148.50M | ||
| 1989 | $532.40M | +19.5% | +$86.90M | ||
| 1988 | $445.50M | -8.2% | −$39.80M | ||
| 1987 | $485.30M | +15.1% | +$63.70M | ||
| 1986 | $421.60M | +20.8% | +$72.60M | ||
| 1985 | $349.00M | — | — |
- 2025$3.96B-18.5%
- 2024$4.85B+14.3%
- 2023$4.25B+25.9%
- 2022$3.37B-10.3%
- 2021$3.76B-13.5%
- 2020$4.35B+8.3%
- 2019$4.01B-3.7%
- 2018$4.17B+1.3%
- 2017$4.12B-5.0%
- 2016$4.33B+29.4%
- 2015$3.35B-18.5%
- 2014$4.11B-0.4%
- 2013$4.12B-5.9%
- 2012$4.38B+2.6%
- 2011$4.27B+10.3%
- 2010$3.87B-2.7%
- 2009$3.98B+15.0%
- 2008$3.46B+12.9%
- 2007$3.06B+19.9%
- 2006$2.55B-2.0%
- 2005$2.61B+4.2%
- 2004$2.50B+1.3%
- 2003$2.47B+6.9%
- 2002$2.31B+6.4%
- 2001$2.17B+4.5%
- 2000$2.08B+5.0%
- 1999$1.98B+9.1%
- 1998$1.81B+8.1%
- 1997$1.68B+7.4%
- 1996$1.56B+9.6%
- 1995$1.43B+11.0%
- 1994$1.28B+10.4%
- 1993$1.16B+17.4%
- 1992$991.10M+131.7%
- 1991$427.80M-37.2%
- 1990$680.90M+27.9%
- 1989$532.40M+19.5%
- 1988$445.50M-8.2%
- 1987$485.30M+15.1%
- 1986$421.60M+20.8%
- 1985$349.00M—
EBITDA values are taken from Colgate-Palmolive's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Colgate-Palmolive (CL)
According to Colgate-Palmolive's latest reported financial statements, the company's current EBITDA (TTM) is $3.71B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Colgate-Palmolive (CL) most recent annual EBITDA stands at $3.96B (2025) – declined 18.5% year-over-year.
Through 2020–2025 (5 years), Colgate-Palmolive EBITDA delivered a -1.9% annualised rate; with a net decline across the window.
Between 2024 and 2025, Colgate-Palmolive EBITDA declined 18.5%, falling from $4.85B to $3.96B.
$4.85B stands as the all-time-high annual EBITDA, posted in 2024, against a low of $349.00M during 1985.
Colgate-Palmolive EBITDA by Year
Colgate-Palmolive EBITDA 2025: $3.96B
In 2025, Colgate-Palmolive reported EBITDA of $3.96B, declined 18.5% below 2024.
Colgate-Palmolive EBITDA 2024: $4.85B
Colgate-Palmolive EBITDA in 2024 was $4.85B, grew 14.3% from 2023. This figure represents the highest annual value in the available history.
Colgate-Palmolive EBITDA 2023: $4.25B
2023's EBITDA for Colgate-Palmolive came in at $4.25B, grew 25.9% from 2022.
Colgate-Palmolive EBITDA 2022: $3.37B
Colgate-Palmolive posted EBITDA of $3.37B in 2022, declined 10.3% below 2021.
Colgate-Palmolive EBITDA 2021: $3.76B
Colgate-Palmolive EBITDA in 2021 was $3.76B.
See more financial history for Colgate-Palmolive (CL).
Sector peers by EBITDA
Consumer Defensive peers of Colgate-Palmolive (CL), ranked by their latest EBITDA
| $46.47B | |
| $23.92B | |
| $18.70B | |
| $17.46B | |
| $15.54B | |
| $13.40B | |
| $10.83B | |
| $2.60B |
- $46.47B
- $23.92B
- $18.70B
- $15.54B
- $13.40B
- $10.83B
- $2.60B
Frequently asked questions
Colgate-Palmolive (CL) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation